NCT02253225

Brief Summary

The investigators propose to examine both resting state activity and functional activity during rumination and during self-processing to study the relationship between neural correlates of rumination/self-focus and self-processing in major depression and bipolar disorder.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2013

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2013

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

September 24, 2014

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 1, 2014

Completed
5.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2020

Completed
Last Updated

September 1, 2021

Status Verified

August 1, 2021

Enrollment Period

7 years

First QC Date

September 24, 2014

Last Update Submit

August 31, 2021

Conditions

Keywords

Bipolar DisorderMajor DepressionRuminationSelf Processing

Outcome Measures

Primary Outcomes (1)

  • Functional Magnetic Resonance Imaging (fMRI) to examine self processing and self focus

    Functional Magnetic Resonance Imaging (fMRI) will be used to look at the neuroanatomy of self processing and self focus.

    Participants will be analyzed as quickly as possible after a screening visit, an expected average of 2 weeks

Study Arms (3)

Bipolar Disorder

Clinical status will be determined using the Mini International Neuropsychiatric Interview (M.I.N.I) for 20 patients with bipolar disorder (BPAD).

Other: Functional Magnetic Resonance Imaging (fMRI)

Major Depressive Disorder

Clinical status will be determined using the Mini International Neuropsychiatric Interview (M.I.N.I) for 20 patients with major depression (MDD).

Other: Functional Magnetic Resonance Imaging (fMRI)

Healthy Control

Clinical status will be determined using the Mini International Neuropsychiatric Interview (M.I.N.I) for 20 normal, healthy volunteers.

Other: Functional Magnetic Resonance Imaging (fMRI)

Interventions

Imaging will be performed on a 3T Siemens Trio scanner. Each MRI scanning session will last no more than 90 minutes.

Bipolar DisorderHealthy ControlMajor Depressive Disorder

Eligibility Criteria

Age18 Years - 64 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Healthy controls will be recruited through email announcements at MGH, internet website at Harvard, and flyers posted at the Massachusetts General Hospital and in the community (e.g., community centers, public libraries, coffee shops, restaurants, and laundromats). Subjects with major depression will be recruited through the Depression Clinic and Research Program at MGH and flyers posted at MGH. Subjects with bipolar disorder will be recruited through the Bipolar Clinic and Research Program at MGH and flyers posted at MGH.

You may qualify if:

  • Right-handed (as determined by the Handedness Inventory; Oldfield, 1971)
  • Normal or corrected-to normal vision and hearing

You may not qualify if:

  • Any current or past psychiatric history
  • Significant medical, psychiatric or neurological illness
  • Currently taking antidepressants, mood stabilizers, or benzodiazepines
  • Positive MR screen (e.g., metal implant, claustrophobia, etc)
  • Current diagnosis of MDD
  • Right-handed (as determined by the Handedness Inventory; Oldfield, 1971)
  • Normal or corrected-to normal vision and hearing
  • If a history of substance abuse, at least 6 months in remission
  • Current suicidal ideation or history of suicide attempts
  • Positive MR screen (e.g., metal implant, claustrophobia, etc)
  • Current diagnosis of BPAD
  • Right-handed (as determined by the Handedness Inventory; Oldfield, 1971)
  • Normal or corrected-to normal vision and hearing
  • If a history of substance abuse, at least 6 months in remission
  • Current suicidal ideation or history of suicide attempts
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Massachusetts General Hospital

Boston, Massachusetts, 02114, United States

Location

MeSH Terms

Conditions

Bipolar DisorderDepressive Disorder, MajorRumination Syndrome

Condition Hierarchy (Ancestors)

Bipolar and Related DisordersMood DisordersMental DisordersDepressive DisorderGastrointestinal DiseasesDigestive System DiseasesFeeding and Eating Disorders

Study Officials

  • Sharmin Ghaznavi, M.D., Ph.D.

    Massachusetts General Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Staff Psychiatrist

Study Record Dates

First Submitted

September 24, 2014

First Posted

October 1, 2014

Study Start

January 1, 2013

Primary Completion

January 1, 2020

Study Completion

January 1, 2020

Last Updated

September 1, 2021

Record last verified: 2021-08

Locations